ICD-10 Coding for Myeloproliferative Disorder(D47.1, D45, D47.3)
Complete ICD-10-CM coding and documentation guide for Myeloproliferative Disorder. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Myeloproliferative Disorder
D45-D47Primary Range
Neoplasms of uncertain behavior of lymphoid, hematopoietic and related tissue
This range includes codes for various myeloproliferative disorders, including Polycythemia Vera, Essential Thrombocythemia, and Chronic Myeloproliferative Disease.
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D47.1 | Chronic myeloproliferative disease | Use for unspecified or unclassifiable myeloproliferative disorders. |
|
| D45 | Polycythemia vera | Use when polycythemia vera is confirmed by lab tests. |
|
| D47.3 | Essential thrombocythemia | Use when essential thrombocythemia is confirmed by exclusion of reactive causes. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for myeloproliferative disorder
Essential facts and insights about Myeloproliferative Disorder
Primary ICD-10-CM Codes for myeloproliferative disorder
Decision Criteria
clinical Criteria
- Presence of JAK2 mutation and splenomegaly.
documentation Criteria
- Explicit mention of chronic myeloproliferative disease.
Applicable To
- Chronic myeloproliferative disorder
Clinical Validation Requirements
- JAK2 mutation
- Splenomegaly
- Thrombocytosis
Code-Specific Risks
- Misclassification if specific subtype is not documented.
Coding Notes
- Ensure specific subtype is documented to avoid using D47.1 as a default.
D45 - Polycythemia vera
Use when polycythemia vera is confirmed by lab tests.
Applicable To
- Primary polycythemia
Excludes
- Secondary polycythemia (D75.1)
Clinical Validation Requirements
- Elevated RBC mass
- JAK2 V617F mutation
Coding Notes
Ensure JAK2 mutation is documented for accurate coding.
D47.3 - Essential thrombocythemia
Use when essential thrombocythemia is confirmed by exclusion of reactive causes.
Applicable To
- Primary thrombocytosis
Excludes
- Reactive thrombocytosis (D75.81)
Clinical Validation Requirements
- Platelet count >450,000/µL
- Absence of BCR-ABL1
Coding Notes
Document exclusion of reactive causes for accurate coding.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Other thrombophilia
D68.69Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Myeloproliferative Disorder to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code D47.1.
Impact
Clinical: Misrepresentation of patient's condition., Regulatory: Potential audit issues., Financial: Incorrect reimbursement rates.
Mitigation Strategy
Verify specific subtype before coding., Consult clinical documentation.
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data representation.
Mitigation Strategy
Require explicit documentation of hypercoagulability.
Impact
Risk of using unspecified codes without supporting documentation.
Mitigation Strategy
Require detailed clinical documentation and lab results.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Myeloproliferative Disorder, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Myeloproliferative Disorder
Use these documentation templates to ensure complete and accurate documentation for Myeloproliferative Disorder. These templates include all required elements for proper coding and billing.
Chronic Myeloproliferative Disease Management
Specialty: HematologyRequired Elements
- Patient history
- Physical examination findings
- Laboratory results
- Treatment plan
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Myeloproliferative Disorder? Ask your questions below.